Fact CheckerSign in

NCT02683681Enrolling by invitation

HF Tissue Registry

Heart Failure Intraoperative Tissue Sample Acquisition Registry

Source: ClinicalTrials.gov · Last updated 14 Apr 2026

Brief summary (registry, in English)

This is a registry study. This is an observational, non-randomized, open, long-term project to collect biological samples (e.g. tissue and blood samples) in addition to clinical information and laboratory test results, from end-stage patients who undergo LVAD implantation and/or heart transplantation. There are no investigational treatments, drug or procedures associated with participation in registry activities. Data collection will not immediately influence the course of treatment for any patient.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
200 (estimated)
First submitted
11 Feb 2016
Start date
Jun 2008
Primary completion date
31 Dec 2036
Lead sponsor
Intermountain Health Care, Inc.
NCT number
NCT02683681

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From Jun 2008 to the primary completion date, 31 Dec 2036
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients will be excluded from the study if any of the following conditions are present:

Age

  • Patients who are less than 18 years of age.

Other

  • The patient or the patient's personal representative is unable or unwilling to give written informed consent for participation.

Who the study is looking for

  • Patients must be in one of the following groups:
    • 1.1. Patients must be eligible for a -
    • LVAD implantation or
    • Heart transplantation 1.2. Patients must be scheduled for another type of cardiac surgery during which tissue is excised that would normally be discarded after surgery.
    • 1.3. Patients must have a VAD already implanted as destination therapy with no cardiac surgery scheduled at the time of consent.
  • Patients must agree to one or more blood and/or cardiac tissue sample donation(s), and longterm storage of these biological samples.
  • Patients must be \> 18 years of age.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.